Maternal Serum Placental Growth Factor, Soluble Fms-Like Tyrosine Kinase-1, and Soluble Endoglin in Twin Gestations and the Risk of Preeclampsia-A Systematic Review

被引:10
作者
Kosinska-Kaczynska, Katarzyna [1 ]
Zgliczynska, Magdalena [1 ,2 ]
Kozlowski, Szymon [3 ]
Wicherek, Lukasz [1 ]
机构
[1] Ctr Postgrad Med Educ, Dept Obstet & Gynecol 2, PL-01809 Warsaw, Poland
[2] Med Univ Warsaw, Lab Ctr Preclin Res, Chair & Dept Expt & Clin Physiol, PL-02106 Warsaw, Poland
[3] Med Univ Warsaw, Univ Ctr Woman & Newborn Hlth, PL-02015 Warsaw, Poland
关键词
placental growth factor; serum soluble fms-like tyrosine kinase-1; endoglin; preeclampsia; prediction; twin pregnancy; SFLT-1/PLGF RATIO; HYPERTENSIVE DISORDERS; ANGIOGENIC FACTORS; PREDICTIVE-VALUE; PREGNANCIES; SINGLETON; OUTCOMES; WOMEN; 1ST; COMPLICATIONS;
D O I
10.3390/jcm9010183
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Multiple gestation is one of the key risk factors for the occurrence of preeclampsia (PE). Soluble fms-like tyrosine kinase-1, placental growth factor, and soluble endoglin are molecules involved in the process of angiogenesis with a proven role in the pathogenesis of PE. The aim of the review was to summarize available data on maternal serum levels of the above-mentioned factors and their usefulness in predicting PE in twin pregnancies. Only original research articles written in English were considered eligible. Reviews, chapters, case studies, conference papers, experts' opinions, editorials, and letters were excluded from the analysis. No publication date limitations were imposed. The systematic literature search using PubMed/MEDLINE, Scopus, Embase, and Cochrane Library databases identified 338 articles, 10 of which were included in the final qualitative analyses. The included studies showed significant differences in maternal serum levels of the discussed factors between women with twin pregnancies with PE and those who did not develop PE, and their promising performance in predicting PE, alone or in combination with other factors. The identification of the most effective algorithms, their prompt introduction to the clinical practice, and further assessment of the real-life performance should become a priority.
引用
收藏
页数:13
相关论文
共 50 条
[41]   Maternal plasma soluble fms-like tyrosine kinase-1 and placental growth factor levels as biochemical markers of gestational hypertension for Malaysian mothers [J].
Nadarajah, Vishna D. ;
Min, Richard G. L. Y. ;
Judson, John P. ;
Jegasothy, Ravindran ;
Ling, Elena H. P. .
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2009, 35 (05) :855-863
[42]   Diagnostic accuracy of the soluble Fms-like tyrosine kinase-1/placental growth factor ratio for preeclampsia: a meta-analysis based on 20 studies [J].
Liu, Yuxiu ;
Zhao, Yang ;
Yu, Ailing ;
Zhao, Bin ;
Gao, Yufang ;
Niu, Haitao .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2015, 292 (03) :507-518
[43]   Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis [J].
Kleinrouweler, C. E. ;
Wiegerinck, M. M. J. ;
Ris-Stalpers, C. ;
Bossuyt, P. M. M. ;
van der Post, J. A. M. ;
von Dadelszen, P. ;
Mol, B. W. J. ;
Pajkrt, E. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2012, 119 (07) :778-787
[44]   Serum soluble FMS-like tyrosine kinase-1 in ectopic pregnancy [J].
Selvarajan, Sathya ;
Ramalingam, Jothimalar ;
Vijayaraghavan, Jaya ;
Bobby, Zachariah .
JOURNAL OF LABORATORY PHYSICIANS, 2019, 11 (04) :335-339
[45]   First-trimester serum soluble fms-like tyrosine kinase-1, free vascular endothelial growth factor, placental growth factor and uterine artery Doppler in preeclampsia [J].
Odibo, A. O. ;
Rada, C. C. ;
Cahill, A. G. ;
Goetzinger, K. R. ;
Tuuli, M. G. ;
Odibo, L. ;
Macones, G. A. ;
England, S. K. .
JOURNAL OF PERINATOLOGY, 2013, 33 (09) :670-674
[46]   First trimester screening of serum soluble fms-like tyrosine kinase-1 and placental growth factor predicting hypertensive disorders of pregnancy [J].
Schneuer, Francisco J. ;
Nassar, Natasha ;
Guilbert, Cyrille ;
Tasevski, Vitomir ;
Ashton, Anthony W. ;
Morris, Jonathan M. ;
Roberts, Christine L. .
PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 2013, 3 (04) :215-221
[47]   Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction [J].
Brownfoot, Fiona C. ;
Hastie, Roxanne ;
Hannan, Natalie J. ;
Cannon, Ping ;
Tuohey, Laura ;
Parry, Laura J. ;
Senadheera, Sevvandi ;
Illanes, Sebastian E. ;
Kaitu'u-Lino, Tu'uhevaha J. ;
Tong, Stephen .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 214 (03) :356.e1-356.e15
[48]   Predictive value of the soluble fms-like tyrosine kinase 1 to placental growth factor ratio for preeclampsia in twin pregnancies: a systematic review and meta-analysis [J].
Yang, Meilin ;
Bai, Yuci ;
Li, Min ;
Lin, Xueyan ;
Duan, Xiaoyu ;
Zhang, Xueqin .
AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM, 2024, 6 (03)
[49]   Midgestation Maternal Serum 25-Hydroxyvitamin D Level and Soluble Fms-Like Tyrosine Kinase 1/Placental Growth Factor Ratio as Predictors of Severe Preeclampsia [J].
Woodham, Padmashree Chaudhury ;
Brittain, Julia E. ;
Baker, Arthur M. ;
Long, D. Leann ;
Haeri, Sina ;
Camargo, Carlos A., Jr. ;
Boggess, Kim A. ;
Stuebe, Alison M. .
HYPERTENSION, 2011, 58 (06) :1120-1125
[50]   Maternal placental growth factor and soluble fms-like tyrosine kinase-1 reference ranges in post-term pregnancies: A prospective observational study [J].
Mitlid-Mork, Birgitte ;
Bowe, Sophie ;
Gran, Jon M. ;
Bolstad, Nils ;
Berg, Jens Petter ;
Redman, Christopher W. ;
Staff, Anne Cathrine ;
Sugulle, Meryam .
PLOS ONE, 2020, 15 (10)